ATE234622T1 - Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen - Google Patents

Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Info

Publication number
ATE234622T1
ATE234622T1 AT96943630T AT96943630T ATE234622T1 AT E234622 T1 ATE234622 T1 AT E234622T1 AT 96943630 T AT96943630 T AT 96943630T AT 96943630 T AT96943630 T AT 96943630T AT E234622 T1 ATE234622 T1 AT E234622T1
Authority
AT
Austria
Prior art keywords
immunogenic
blood cells
red blood
plates
containing non
Prior art date
Application number
AT96943630T
Other languages
English (en)
Inventor
Sherrill J Slichter
Original Assignee
Puget Sound Blood Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puget Sound Blood Ct filed Critical Puget Sound Blood Ct
Application granted granted Critical
Publication of ATE234622T1 publication Critical patent/ATE234622T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
AT96943630T 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen ATE234622T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56684795A 1995-12-04 1995-12-04
PCT/US1996/019467 WO1997020570A1 (en) 1995-12-04 1996-12-04 Non-immunogenic and toleragenic platelet and red blood cell compositions

Publications (1)

Publication Number Publication Date
ATE234622T1 true ATE234622T1 (de) 2003-04-15

Family

ID=24264638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943630T ATE234622T1 (de) 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Country Status (7)

Country Link
EP (1) EP0874635B1 (de)
JP (1) JP2000503631A (de)
AT (1) ATE234622T1 (de)
AU (1) AU725669B2 (de)
CA (1) CA2239574A1 (de)
DE (1) DE69626853T2 (de)
WO (1) WO1997020570A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1902740A1 (de) * 2006-09-19 2008-03-26 Maco Pharma S.A. Blutbeutelsystem und Verfahren, um Pathogene in Blutplättchenkonzentraten mit Hilfe des Blutbeutelsystems zu neutralisieren
KR102058568B1 (ko) 2011-10-17 2020-01-22 메사추세츠 인스티튜트 오브 테크놀로지 세포 내 전달
SG11201601927SA (en) 2013-08-16 2016-04-28 Massachusetts Inst Technology Selective delivery of material to cells
KR20230098928A (ko) 2014-10-31 2023-07-04 메사추세츠 인스티튜트 오브 테크놀로지 면역 세포로의 생체분자의 전달
CA2964138C (en) 2014-11-14 2023-11-14 Massachusetts Institute Of Technology Disruption and field enabled delivery of compounds and compositions into cells
JP2018504395A (ja) * 2014-12-31 2018-02-15 アンソロジェネシス コーポレーションAnthrogenesis Corporation 血小板の分離方法
CN107250373A (zh) 2015-01-12 2017-10-13 麻省理工学院 通过微流体递送实现的基因编辑
WO2017008063A1 (en) 2015-07-09 2017-01-12 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
EP3344575B1 (de) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intrazelluläres einbringen von biomolekülen in zellen mit einer zellwand

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714524A (en) * 1980-07-02 1982-01-25 Asahi Chem Ind Co Ltd Preparation of dispersion of platelet
JPS5762222A (en) * 1980-10-03 1982-04-15 Asahi Chem Ind Co Ltd Preparation of concentrated solution of platelet, its device and part
DE3650139T2 (de) * 1985-07-05 1995-03-09 Puget Sound Blood Center And P Verfahren zum reduzieren der immunogenizität und zum induzieren immunologischer toleranz.
AU578554B2 (en) * 1986-01-24 1988-10-27 Japanese Red Cross Society Centrifugal method of separating blood components
WO1991004088A1 (en) * 1989-09-12 1991-04-04 Pall Corporation Device and method for processing blood for human transfusion
DE4129516C2 (de) * 1991-09-06 2000-03-09 Fresenius Ag Verfahren und Vorrichtung zum Trennen von Blut in seine Bestandteile

Also Published As

Publication number Publication date
CA2239574A1 (en) 1997-06-12
WO1997020570A1 (en) 1997-06-12
AU1282597A (en) 1997-06-27
EP0874635B1 (de) 2003-03-19
DE69626853T2 (de) 2004-02-19
AU725669B2 (en) 2000-10-19
JP2000503631A (ja) 2000-03-28
DE69626853D1 (de) 2003-04-24
EP0874635A1 (de) 1998-11-04

Similar Documents

Publication Publication Date Title
IS4226A (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
DE3161494D1 (en) Cosmetic preparations
DE69620877T2 (de) Arzneimittelformulierungen für il-12
NO20003698D0 (no) Orale sammensetninger
ATE106740T1 (de) Herstellung von t-zellen und t-zellmembranen, verwendbar zur verhütung und behandlung von autoimmunkrankheiten.
NO960743L (no) Cellulære preparater, deres fremstilling og terapeutiske anvendelse
TR200101549T2 (tr) p53-Familyasından bir proteinin yapısal kararlılığının canlandırılmasına yönelik metotlar.
IT8422580A0 (it) Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle.
MX9603074A (es) Vitamina e y derivados que previenen el daño en celulas rojas esterilizadas mediante ftalocianinas y luz.
ES2173887T3 (es) Nuevos usos farmaceuticos de las enzimas de krill.
ATE234622T1 (de) Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
EP0689586B8 (de) Funktion und aktivität des viralen proteins r (vpr)
ATE321843T1 (de) Zellen, kulturverfahren, und ihre verwendung in autologer transplantationstherapie
IT8125135A0 (it) Procedimento per l'idrolizzazione in sito di una membrana permeabile agli ioni di una cella elettrolitica utilizzante tale membrana.
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DK161384C (da) Pyrazolooe3,4,5-klaaacridinforbindelser og farmaceutiske praeparater indeholdende saadanne forbindelser
IL83990A0 (en) Cell membrane proteins,compositions containing them and procedure for their preparation
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
DK0925064T3 (da) 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst
BR9812002A (pt) Compostos com efeito antiprimeiro-passe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties